MassGeneral Institute for Neurodegenerative Disease

Translating today's discoveries into tomorrow's cures

Facebook icon Twitter Icon

About Page Banner

About This Center

MassGeneral Institute for Neurodegenerative Disease (MIND) is committed to finding treatments and cures to improve the lives of patients with neurodegenerative disorders including Alzheimer’s, Amyotrophic Lateral Sclerosis (ALS), Huntington’s and Parkinson’s disease. Founded in 2001, MIND unites scientists and physician-scientists with the common goal of translating laboratory findings into the clinic where they can reach patients. Researchers in MIND laboratories work collaboratively to address important research questions and maximize synergy to yield the most promising results.